{"id":49158,"date":"2022-10-04T23:01:38","date_gmt":"2022-10-04T21:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"},"modified":"2022-10-04T23:01:38","modified_gmt":"2022-10-04T21:01:38","slug":"tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","title":{"rendered":"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–$TNDM<\/a>–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the financial markets close on Wednesday, November 2, 2022. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2022 financial and operating results.\n<\/p>\n

<\/a><\/p>\n

\nA live webcast of the call will be available on Tandem Diabetes Care\u2019s Investor Center website located at http:\/\/investor.tandemdiabetes.com<\/a> in the \u201cEvents & Presentations\u201d section. To access the call by phone, please use this link (Registration Link<\/a>) and you will be provided with dial-in details, including a personal pin.\n<\/p>\n

\nAn archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care\u2019s Investor Center website located at http:\/\/investor.tandemdiabetes.com<\/a> in the \u201cEvents & Presentations\u201d section.\n<\/p>\n

\nAbout Tandem Diabetes Care, Inc.<\/b>\n<\/p>\n

\nTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company\u2019s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com<\/a>.\n<\/p>\n

\nTandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and\/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.\n<\/p>\n

\nFollow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
\n
Follow Tandem Diabetes Care on Facebook at www.facebook.com\/TandemDiabetes<\/a>.
\n
Follow Tandem Diabetes Care on LinkedIn at https:\/\/www.linkedin.com\/company\/tandemdiabetes<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Steve Sabicer
\n
714-907-6264
\n
ssabicer@thesabicergroup.com<\/a>\n<\/p>\n

\nInvestor Contact:<\/b>
Susan Morrison
\n
858-366-6900
\n
IR@tandemdiabetes.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–$TNDM–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the financial markets close on Wednesday, November 2, 2022. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49158","6":"format-standard","7":"category-industry"},"yoast_head":"\nTandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–$TNDM–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the financial markets close on Wednesday, November 2, 2022. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-04T21:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221004005999\/en\/1349177\/21\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022\",\"datePublished\":\"2022-10-04T21:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\"},\"wordCount\":323,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005999\\\/en\\\/1349177\\\/21\\\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\",\"name\":\"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005999\\\/en\\\/1349177\\\/21\\\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg\",\"datePublished\":\"2022-10-04T21:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005999\\\/en\\\/1349177\\\/21\\\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005999\\\/en\\\/1349177\\\/21\\\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","og_locale":"en_US","og_type":"article","og_title":"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–$TNDM–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the financial markets close on Wednesday, November 2, 2022. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-04T21:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221004005999\/en\/1349177\/21\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022","datePublished":"2022-10-04T21:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"},"wordCount":323,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005999\/en\/1349177\/21\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","url":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","name":"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005999\/en\/1349177\/21\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg","datePublished":"2022-10-04T21:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221004005999\/en\/1349177\/21\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221004005999\/en\/1349177\/21\/2022_02_01_Tandem_Horizontal_Logo_New_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tandem-diabetes-care-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49158"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49158\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}